Geode Capital Management
MGRM

Geode Capital Management’s Monogram Orthopaedics MGRM Stock Holding History

Geode Capital Management’s Portfolio MGRM Stock Details MGRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-261,722
Closed -$1.54M – 4525
2025
Q3 		$1.54M Buy
261,722
+18,344
+8% +$98K ﹤0.01% 3271
2025
Q2 		$703K Sell
243,378
-29
-0% -$78 ﹤0.01% 3446
2025
Q1 		$716K Buy
243,407
+17,029
+8% +$45K ﹤0.01% 3417
2024
Q4 		$537K Buy
226,378
+16,234
+8% +$38.1K ﹤0.01% 3577
2024
Q3 		$557K Buy
210,144
+194,776
+1,267% +$507K ﹤0.01% 3553
2024
Q2 		$33K Hold
15,368
– – ﹤0.01% 4368
2024
Q1 		$37.5K Hold
15,368
– – ﹤0.01% 4376
2023
Q4 		$52.9K Hold
15,368
– – ﹤0.01% 4336
2023
Q3 		$40K Buy
15,368
+2,649
+21% +$11.1K ﹤0.01% 4470
2023
Q2 		$50.6K Buy
+12,719
New +$65.8K ﹤0.01% 4504

Geode Capital Management's MGRM Position: Q4 2025 in Review

Geode Capital Management sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 261,722 shares — an estimated $1.54M sold.

Geode Capital Management first reported a position in MGRM in Q2 2023 and held it in 10 quarters. The position peaked at $1.54M in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

  • Geode Capital Management reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
  • Geode Capital Management sold 261,722 Monogram Orthopaedics shares in Q4 2025, an estimated $1.54M.
  • Geode Capital Management first reported a position in Monogram Orthopaedics in Q2 2023 and held it in 10 quarters.
  • Geode Capital Management's Monogram Orthopaedics position peaked at $1.54M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on Geode Capital Management's 13F filing for Q4 2025, filed 9 Feb 2026.